Footnotes

• Twitter @rum_thomas11

• Contributors NW and RT agreed a joint viewpoint. NW drafted the manuscript and both authors revised the original draft.

• Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

• Competing interests NW and RT cochaired the task and finish British Society for Paediatric Endocrinology and Diabetes working group responsible for reviewing and revising the guidelines to produce the interim guidance.

• Provenance and peer review Commissioned; externally peer reviewed.

• Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.